MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)

Recruiting

Early Phase 1

MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)

Sponsor:

Austin V Stone

Code:

NCT04572256

Conditions

ACL Injury

Meniscus Tear

Post-traumatic Osteoarthritis

Eligibility Criteria

Sex: All

Age: 25 - 50

Healthy Volunteers: Not accepted

Interventions

Montelukast

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Austin V Stone on 2025-05-08.